R&D News | pharmaphorum

News

Billions of dollars will be cut from medical research funding provided by the NIH in the latest money-saving programme from the Trump administration.

News

MSD has started a phase 3 trial of ROR1-directed ADC zilo-V as a treatment for previously untreated diffuse large B-cell lymphoma.

News

After its first phase 3 trial of obesity hope CagriSema left investors dissatisfied, Novo Nordisk has a plan to get the programme back on track.

News

Robert F Kennedy Jr has cleared a key obstacle in his bid to become the next HHS Secretary after the Senate Finance Committee voted in his favour.

News

A GABA-targeting drug developed by German Biotech Algiax has shown proof of concept in a chronic neuropathic trial trial.

News

Nearly 700,000 women will be recruited into an NHS trial of AI tools for breast cancer screening, in the hope of relieving pressure on radiologists.